tributyrin: Clinical Trials

14 trials of tributyrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 recruiting, 3 not yet recruiting, 2 terminated. 7 Not applicable, 4 Phase 1, 2 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 3, Recruiting 2, Not yet recruiting 1, Terminated 1
Phase 14Recruiting 2, Completed 1, Terminated 1
Phase 22Recruiting 2
Phase 32Not yet recruiting 2
Early Phase 11Withdrawn 1

Follow tributyrin: new trials by email Literature Review of tributyrin trials Research Report on tributyrin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Tributyrin, Placebo - Parkinson Disease, Multiple System Atrophy
Phase 1 / Phase 2RecruitingPrabesh Kanel152026-10-012026-11-05
A Prospective, Single-Arm Clinical Study of a Dietary Supplement for the Prevention of Acute Radiation-Induced Rectal Injury During Neoadjuvant Chemoradiotherapy for Rectal Cancer
Tributyrin - Radiotherapy, Radiation-Induced Complications
Not applicableRecruitingSixth Affiliated Hospital, Sun Yat-sen University232026-07-012026-09-03
Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
tributyrin, Placebo - Alzheimer Disease (AD)
Phase 3Not yet recruitingUniversidad de Almeria1562026-06-012025-12-18
Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes
tributyrin, Placebo - Diabete Mellitus
Phase 3Not yet recruitingAin Shams University602026-03-262026-03-31
The Metabolic Effects of Oral Tributyrin Administration
tributyrin, Control - Healthy Overweight/Obese
Not applicableRecruitingUniversity of Aarhus122026-02-202026-03-16
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Tributyrin, Placebo - Parkinson Disease, Parkinson Disease Dementia
Phase 1 / Phase 2RecruitingPrabesh Kanel452025-11-072025-11-12
A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems
Lipase Thera-blend, Lipase Thera-blend + tributyrin, Placebo - Self-reported Memory Problems, Memory
Not applicableCompletedEnzymedica902025-08-252026-03-31
ButOx Human Trial: An Open Label Prospective Cohort Study to Investigate the Effect of Tributyrin (Butyrate Precursor Molecule) Supplementation on Markers of Calcium Oxalate Nephrolithiasis
tributyrin - Urolithiasis
Not applicableNot yet recruitingUniversity of British Columbia102025-07-012025-06-04
Tributyrin: Time Course & Efficacy to Improve Health & Performance
CoreBiome, Placebo - Metabolite Concentration, Gut Permeability
Not applicableTerminatedFlorida State University42024-08-192025-04-13
Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell Transplantation
Tributyrin - Hematopoietic Cell Transplantation (HCT)
Early Phase 1WithdrawnDuke University2024-08-012024-08-15
A Pharmacokinetic Comparison of Three Butyrate Products
Lysine butyrate, Sodium Butyrate, Tributyrin - Gastro-Intestinal Disorder
Not applicableCompletedThe Center for Applied Health Sciences, LLC102024-05-032024-11-22
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
tributyrin - Parkinson Disease
Phase 1TerminatedNicolaas Bohnen, MD, PhD182022-07-012025-01-23
Fat-induced Release of GLP-1 in Humans
Tributyrin, C8-diet oil, Olive oil - Type 2 Diabetes
Not applicableCompletedGlostrup University Hospital, Copenhagen122013-10-012014-10-15
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
chemotherapy, tributyrin - Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
Phase 1CompletedUniversity of Maryland, Baltimore241995-08-012019-11-04

Conditions studied

Parkinson Disease (3)  ·  Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Digestive System Diseases (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Kidney Calculi (1)  ·  Multiple System Atrophy (1)  ·  Obesity (1)  ·  Prostatic Neoplasms (1)  ·  Supranuclear Palsy, Progressive (1)  ·  Urolithiasis (1)

Sponsors

Prabesh Kanel (2)  ·  Ain Shams University (1)  ·  Duke University (1)  ·  Enzymedica (1)  ·  Florida State University (1)  ·  Glostrup University Hospital, Copenhagen (1)  ·  Nicolaas Bohnen, MD, PhD (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  The Center for Applied Health Sciences, LLC (1)  ·  Universidad de Almeria (1)  ·  University of Aarhus (1)  ·  University of British Columbia (1)  ·  University of Maryland, Baltimore (1)

Countries

United States (6)  ·  Canada (2)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Spain (1)

Top investigators

Prabesh Kanel, PhD (2)  ·  David A. Van Echo, MD (1)  ·  David Crowley, MD (1)  ·  Jens J Holst, Professor (1)  ·  Nicolaas I Bohnen, MD, PhD (1)

Results publications

PMID 26178726